Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Vivanza Biosciences Ltd

NSE: VIVANZA · BSE: 530057 · Pharmaceuticals & Biotechnology · 3 announcements

Share price: ₹1.77
Market cap: ₹7.08 Cr
Revenue (annual): ₹115.9 Cr
Net profit (annual): ₹0.39 Cr
P/E (TTM): 15.6×Sector 50.4×
Promoter holding: 20.02%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

7 Aug 2026 13:12 IST BSE

Financial Results

Vivanza Biosciences Q1 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% YoY

Vivanza Biosciences Ltd reported revenue from operations of ₹9.3 Cr (+4.5% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q1 FY27.

Key figure: Net profit ₹0.1 Cr · +0.0% YoY

Open full results → Read the filing ↗

7 May 2026 22:58 IST BSE

Financial Results

Vivanza Biosciences Q4 FY26 Results: Net Loss of ₹0.5 Cr, Loss Narrows

Vivanza Biosciences Ltd reported revenue from operations of ₹6.4 Cr (+1180.0% YoY) and a net loss of ₹0.5 Cr for Q4 FY26.

Key figure: Net loss ₹0.5 Cr

Open full results → Read the filing ↗